Medicare Enrolled

Dr. Marci Roy, M.D.

Neurology · Kyle, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
4036 CROMWELL DR, Kyle, TX 78640
5126544600
Registered in NPPES since 2005
NPI: 1457356073 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Roy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Roy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Roy

Dr. Marci Roy is a neurology specialist in Kyle, TX, with 21 years of NPI registration. Based on federal Medicare data, Dr. Roy performed 21,135 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Roy received a total of $19,005 from 41 pharmaceutical and/or device companies across 878 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Roy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration ▲ Top 3% volume in TX $19,005 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
21,135
Medicare services
Top 3% in TX for neurology
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
20,665 $5 $19
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
93 $118 $411
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
88 $76 $278
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
87 $92 $209
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
47 $65 $142
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
41 $78 $210
New patient office visit, complex (60-74 min) 34 $167 $399
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
31 $10 $49
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
22 $156 $736
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
14 $191 $863
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
13 $139 $608
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$19,005
Total received (2018-2024)
Avg $2,715/year across 7 years
Top 17% in TX for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
878
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,087
2023
$1,767
2022
$2,025
2021
$2,057
2020
$1,996
2019
$2,103
2018
$6,970

Payments by company (2024)

PFIZER INC.
$707
ABBVIE INC.
$476
Lilly USA, LLC
$305
Teva Pharmaceuticals USA, Inc.
$295
SCILEX PHARMACEUTICALS INC.
$108
ARGENX US, INC.
$89
Takeda Pharmaceuticals U.S.A., Inc.
$43
Abbott Laboratories
$35
Alnylam Pharmaceuticals Inc.
$29
Top 3 companies account for 71.3% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$6,462
PFIZER INC.
$1,438
Amgen Inc.
$1,260
Teva Pharmaceuticals USA, Inc.
$1,150
CSL Behring
$973
ABBVIE INC.
$908
AbbVie Inc.
$868
Novartis Pharmaceuticals Corporation
$639
Supernus Pharmaceuticals, Inc.
$566
Biohaven Pharmaceutical Holding Company Ltd.
$540
Allergan, Inc.
$473
Biohaven Pharmaceuticals, Inc.
$399
Alexion Pharmaceuticals, Inc.
$373
Zyla Life Sciences
$319
Lundbeck LLC
$304
Allergan Inc.
$262
Amneal Pharmaceuticals LLC
$261
Upsher-Smith Laboratories LLC
$197
Promius Pharma LLC
$161
Bausch Health US, LLC
$152
Egalet US Inc
$143
Takeda Pharmaceuticals U.S.A., Inc.
$125
Avanir Pharmaceuticals, Inc.
$114
Assertio Therapeutics, Inc.
$110
SCILEX PHARMACEUTICALS INC.
$108
Grifols USA, LLC
$94
ARGENX US, INC.
$89
UPSHER-SMITH LABORATORIES LLC
$85
NATUS MEDICAL INCORPORATED
$61
Abbott Laboratories
$51
Collegium Pharmaceutical, Inc.
$49
Octapharma USA, Inc.
$49
Alnylam Pharmaceuticals Inc.
$46
IMPEL PHARMACEUTICALS INC.
$42
Mitsubishi Tanabe Pharma America, Inc.
$31
Impax Laboratories, Inc.
$25
Scilex Pharmaceuticals Inc.
$21
Arbor Pharmaceuticals, Inc.
$20
Shire North American Group Inc
$13
BioDelivery Sciences International, Inc.
$13
Zyla Life Sciences, Inc.
$11
Top 3 companies account for 48.2% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · Aimovig · Austedo XR · BELBUCA · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · COMIRNATY · Cambia · ELYXYB - celecoxib · EMGALITY · Evekeo ODT · GAMMAGARD · GILENYA · GIVLAARI · Gamunex-C · Gralise · HYQVIA · Hizentra · LYRICA · MIGRANAL · NURTEC ODT · OCTRODE · ONPATTRO · ONZETRA Xsail · OXTELLAR XR · PANZYGA · PAXLOVID · PROCLAIM · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Radicava · SOLIRIS · SPRIX · Soliris · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · Trudhesa · UBRELVY · VYEPTI · VYVGART · VYVGART HYTRULO · ZAVZPRET · ZIPSOR · ZOMIG · ZORVOLEX · ZTLido · Zembrace · Zembrace SymTouch Sumatriptan Injection · Zipsor
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in Kyle?
Compare neurologists in the Kyle area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
96
County median income
$85,827
Nearest hospital to ZIP centroid (approximate)
ASCENSION SETON HAYS
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Roy is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Roy experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Roy performed 20,665 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Roy receive payments from pharmaceutical companies?
Yes. Dr. Roy received a total of $19,005 from 41 companies across 878 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Roy's costs compare to other neurologists in Kyle?
Dr. Roy's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Roy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →